ampelopsin has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adylova, A; Alhewairini, SS; Attar, R; Avnioglu, S; Buha, A; Fayyaz, S; Pawlak-Adamska, E; Qureshi, MZ; Sabitaliyevich, UY; Salahuddin, H; Tahir, F | 1 |
| Chen, N; Fan, J; Kou, X | 1 |
| Ding, P; Ji, G; Wang, J; Wang, Y; Wu, T; Xiang, H | 1 |
| Chen, L; Liu, S; Lu, X; Lv, C; Qin, S; Shi, M; Song, Y; Wu, Y; Zheng, Z | 1 |
| Chow, LM; Duan, LX; Hu, X; Jiang, T; Li, XM; Liu, T; Liu, Z; Wan, SB; Wang, BC; Wong, IL; Yuan, J; Zhang, XY | 1 |
3 review(s) available for ampelopsin and Neoplasms
| Article | Year |
|---|---|
Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Stress; Flavonoids; Humans; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Reactive Oxygen Species | 2017 |
Recent update on application of dihydromyricetin in metabolic related diseases.
Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Cell Death; Flavonols; Glucose; Humans; Lipid Metabolism; Liver Diseases; Metabolic Diseases; MicroRNAs; Neoplasms; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2022 |
Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention.
Topics: Animals; Anti-Inflammatory Agents; Flavonols; Humans; Neoplasms; Oxidative Stress | 2021 |
2 other study(ies) available for ampelopsin and Neoplasms
| Article | Year |
|---|---|
Regulation of signaling pathways by Ampelopsin (Dihydromyricetin) in different cancers: exploring the highways and byways less travelled.
Topics: Animals; Apoptosis; Flavonoids; Flavonols; Humans; Neoplasms; Signal Transduction | 2019 |
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Catechin; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonols; Humans; Methylation; Models, Molecular; Molecular Structure; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |